Report Categories
View AllRecent Articles
View All
Privia Health CEO Sells Over 27 Million in Company Stock Insider Activity Draws Market Attention
MuskAltman Trial Exposes Rivalries and Governance Questions in AI Sector
Generate Biomedicines GENB Q1 2026 Earnings Miss EPS 106 vs 051 Expected
Five Star FSBC Reports Strong Q1 2026 Revenue NA EPS Beats
Spacex Scrubs Starship V3 Debut Launch Retry Scheduled for Friday
Markets Bet Trump Cannot Sustain 100 Oil Traders Signal
South Korea Deputy PM Calls for Public Benefit from AI Wealth Amid Samsung Labor Tensions
European Companies Strengthen China Manufacturing Ties Amid EU DeRisking Strategy
MGM Resorts Surges Above Buy Point Leads SP 500 on Analyst Upgrades and Las Vegas Recovery Hopes
CDZIP Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction
Novagold Resources NG Q1 2026 Earnings Narrower Loss Drives 74 Stock Gain
ADIL Q1 2026 Earnings Narrowed Loss Beats Estimates but Market Remains Cautious
Beyond Air Inc XAIR Q1 2026 Earnings Narrowing Loss Beats Street Expectations
Global Self Storage Inc SELF Q4 2025 Earnings EPS Falls Short of Estimates as Revenue Details Remain Undisclosed
MidCap Financial Investment 800 Notes 2028 MFICL Edge Higher in Quiet Trading
Smurfit WestRock SW Shows Modest Uptick as Stock Holds Above Support
Upland Software UPLD Hovers Near Support as Selling Pressure Persists
NexGel Inc Warrant NXGLW Holds at 005 After Slight Decline Tight Range Signals Caution
US Treasury Yields Edge Lower as Iran Peace Deal Optimism Tempers Geopolitical Uncertainty
OpenAI Takes the Lead in AI IPO Horse Race Confidential Filing Anticipated
Solanas 2026 Outlook Evaluating the Blockchain Platforms Investment Potential
German Business Morale Unexpectedly Improves in May Amid Iran Conflict Energy Disruptions
Skillz Inc SKLZ Surges Over 6 Breaking Above Key Support Amid Renewed Momentum
Haoxi Health Technology HAO Plunges 187 Testing Critical Support Zone
Meshflow Acquisition Corp MESH Holds Steady at 999 as Consolidation Continues
Akebia Therapeutics AKBA Edges Higher at 104 Key Levels in Focus
Damora Therapeutics DMRA Gains 24 as Biotech Sector Finds Footing
First Capital Inc FCAP Gains 095 Resilience Near Support Zone After Modest Rally